Review

Nature Reviews Drug Discovery 7, 575-590 (July 2008) | doi:10.1038/nrd2605

Purinergic signalling and disorders of the central nervous system

Geoffrey Burnstock1  About the author

Top

Purines have key roles in neurotransmission and neuromodulation, with their effects being mediated by the purine and pyrimidine receptor subfamilies, P1, P2X and P2Y. Recently, purinergic mechanisms and specific receptor subtypes have been shown to be involved in various pathological conditions including brain trauma and ischaemia, neurodegenerative diseases involving neuroimmune and neuroinflammatory reactions, as well as in neuropsychiatric diseases, including depression and schizophrenia. This article reviews the role of purinergic signalling in CNS disorders, highlighting specific purinergic receptor subtypes, most notably A2A, P2X4 and P2X7, that might be therapeutically targeted for the treatment of these conditions.

Author affiliations

  1. Autonomic Neuroscience Centre, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK.
    Email: g.burnstock@ucl.ac.uk

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Neuroscience The brain's garbage men

Nature News and Views (26 Apr 2007)

Vessel tone and remodeling

Nature Medicine News and Views (01 Jan 2006)

See all 5 matches for News And Views

Extra navigation

Search PubMed for

Open Innovation Challenges

naturejobs

natureproducts


Advertisement